Internal Medicine, Infectious Disease · North Palm Beach, FL
NPI
1750342689
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
840 US Hwy One, Suite 120
North Palm Beach, FL, 33408
Phone (561) 776-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$374K
5,070 services
Medicare patients, 2024
627
Average age 79
Drug cost, 2024
$5.0M
4,246 prescriptions
Company payments, 2025
$1,518
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Leslie E Diaz was code 99232 (hospital e&m - subsequent), 4,154 times for 589 patients. In total Leslie E Diaz billed 5,070 services in 7 codes, and Medicare paid $374K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-06-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 4,154 | 589 | $61.93 | $257K |
| 99223 Hospital E&M - Initial | Facility | 785 | 587 | $132.79 | $104K |
| 99233 Hospital E&M - Subsequent | Facility | 124 | 89 | $92.93 | $12K |
By year: 2022 $525K for 7,090 services; 2023 $377K for 4,953 services; 2024 $374K for 5,070 services.
Medicare prescription drug claims, 2024
In 2024, the drug Leslie E Diaz prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 304 prescriptions and refills. In total Leslie E Diaz wrote 4,246 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 304 | 304 | 33 | $1.2M |
| Tivicay Dolutegravir Sodium | 200 | 214 | 21 | $573K |
| Descovy Emtricitabine/Tenofov Alafenam | 145 | 159 | 15 | $343K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 138 | 144 | 17 | $660K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 118 | 222 | 46 | $4,922 |
| Atorvastatin Calcium Generic | 84 | 172 | 19 | $504 |
| Mounjaro Tirzepatide | 81 | 90 | 19 | $90K |
| Amlodipine Besylate Generic | 74 | 142 | 19 | $246 |
| Dovato Dolutegravir Sodium/Lamivudine | 72 | 74 | Under 11 | $216K |
| Sodium Chloride 0.9 % Sodium Chloride | 71 | 71 | 29 | $1,579 |
| Doxycycline Hyclate Generic | 70 | 120 | 30 | $1,313 |
| Lisinopril Generic | 69 | 129 | 16 | $456 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 67 | 67 | Under 11 | $251K |
| Methenamine Hippurate Generic | 66 | 147 | 23 | $6,042 |
| Azithromycin Generic | 66 | 137 | 29 | $2,352 |
Brand drugs: 1,690 claims; generic drugs: 2,519 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Leslie E Diaz $1,518 ($1,518 in general payments such as food, travel and fees) from 7 companies. The largest payer was ViiV Healthcare Company with $842.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.